Skip to main content
. 2017 Apr 19;42(12):2292–2300. doi: 10.1038/npp.2017.63

Figure 3.

Figure 3

Survival (a), body weight loss trajectory (b), average daily running wheel activity (RWA) (c) and mean daily food intake (d) in rats treated with clozapine-n-oxide (CNO; activated, n=10) or saline (control, n=14) to prevent activity-based anorexia (ABA). Results expressed as mean±SEM, *p<0.01.